Cargando…
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
BACKGROUND: Mesenchymal stem cells (MSCs) have been considered to be the attractive vehicles for delivering therapeutic agents toward various tumor diseases. This study was to explore the distribution pattern, kinetic delivery of adenovirus, and therapeutic efficacy of the MSC loading of E1A mutant...
Autores principales: | Xia, Xi, Ji, Teng, Chen, Pingbo, Li, Xiao, Fang, Yong, Gao, Qinglei, Liao, Shujie, You, Lanying, Xu, Hongbin, Ma, Quanfu, Wu, Peng, Hu, Wencheng, Wu, Mingfu, Cao, Li, Li, Kezhen, Weng, Yanjie, Han, Zhiqiang, Wei, Junchen, Liu, Ronghua, Wang, Shixuan, Xu, Gang, Wang, Daowen, Zhou, Jianfeng, Ma, Ding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215929/ https://www.ncbi.nlm.nih.gov/pubmed/22054049 http://dx.doi.org/10.1186/1476-4598-10-134 |
Ejemplares similares
-
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
por: Xia, Xi, et al.
Publicado: (2011) -
Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer
por: Ashshi, Ahmad Mohammad, et al.
Publicado: (2016) -
Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
por: Sakhawat, Ali, et al.
Publicado: (2017) -
Knockdown of CRAD suppresses the growth and promotes the apoptosis of human lung cancer cells via Claudin 4
por: Cui, Anfang, et al.
Publicado: (2020) -
A Systematic Comparison of the Anti-Tumoural Activity and Toxicity of the Three Adv-TKs
por: Gao, Qinglei, et al.
Publicado: (2014)